MyMetabolon Login
© 2021 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Microbiome
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
    • Publications
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
    • Publications
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Respiratory Disorders

Discover actionable biomarkers across the spectrum with non-invasive methods

The National Center for Health Statistics estimates that more than 25 million people in the U.S. have asthma and approximately 14.8 million adults have been diagnosed while 12 million remain undiagnosed.1,2 Respiratory diseases pose a tremendous burden on society and healthcare systems globally, with the World Health Organization reporting that the top five respiratory diseases account for 17.4% of deaths.

While asthma has a low fatality rate, it affects 150 million people worldwide and is the most prevalent chronic childhood disease. Still there are more respiratory disorders like chronic obstructive pulmonary disease (COPD), chronic bronchitis, lung cancer, cystic fibrosis, pneumonia, plural effusion and infectious diseases like influenza and COVID-19 where metabolomics is useful in helping to decode disease mechanisms and more.

TALK WITH AN EXPERT
See More Solutions
Unlock disease mechanisms and support patient stratification

More understanding is needed about the aspects of disease occurrence and severity in respiratory disorders. Global metabolomics can be applied to cultured cells, tissues from model organisms, and patient biopsies to discover metabolic drivers of processes such as cell death and malignant transformation. These insights can be translated into actionable biomarkers through follow-on targeted assays.

Build diagnostics and targets

Respiratory disorders are varied and involve distinct pathways. A narrow focus isn’t enough to understand the intricacy of these diseases in order to develop effective drug targets. Leveraging global metabolomics as a wide-angle tool will support the development of non-invasive diagnostics and therapeutics that have the capability to improve the lives of patient.

1. Bloom B, Jones LI, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10(258). 2013.

2. Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10(260). 2014.

3. https://www.who.int/respiratory/publications/strategy/en/index1.html#:~:text=According%20to%20the%20WHO%20World,Adjusted%20Life%20Years%20(DALYs).

Study Design

Data Interpretation

Our Platform

Learn More

Related Resources

See All Resources
Finding Success with Metabolon: How Pharma Companies Utilize Metabolomics to Advance Therapies

Finding Success with Metabolon: How Pharma Companies Utilize Metabolomics to Advance Therapies

eBrochure: Precision Metabolomics™ Global Assay

eBrochure: Precision Metabolomics™ Global Assay

eBrochure: Metabolomics – Advancing Life Science Research & Improving Health

eBrochure: Metabolomics – Advancing Life Science Research & Improving Health

Load more

Enlighten your research,
accelerate your discovery.

Demo Our Data

Contact Us

Talk with an expert

Request a quote for our services or more information on sample types and handling procedures, need a letter of support, or simply have questions about how metabolomics can advance your research.

    Get a Project Quote
    Send a Message
    Corporate Headquarters

    617 Davis Drive, Suite 100
    Morrisville, NC 27560

    Mailing Address:
    P.O. Box 110407
    Research Triangle Park, NC  27709

    +1 (919) 572-1711
    +1 (919) 572-1721
    International Headquarters

    Metabolon GmbH

    Zeppelinstraße 3
    85399 Hallbergmoos
    Germany

    +49 89 99017752

    Metabolomics

    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Insights & Discoveries

    Solutions

    • Products & Services
    • By Research & Development Phase
    • By Therapeutic Area
    • By Sector

    Insights

    • Our Latest Insights
    • Blog
    • News & Events
    • Publications

    Resources

    • Resource Library
    • Client Stories
    • COVID-19

    Company

    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
    Metabolon - Logo - Enlightening Life

    Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

    © 2022 Metabolon, Inc. All rights reserved. Privacy & Terms

    in